Group B vitamins in treatment of alcoholic and diabetic polyneuropathies


Cite item

Full Text

Abstract

It is describes the role of vitamins B (thiamine, pyridoxine and cyanocobalamin) in the treatment of the diseases of peripheral nervous system, particularly alcoholic polyneuropathy (APN) and diabetic polyneuropathy (DPN). Using of large doses of neurotropic vitamins contained in drugs Milgamma and Milgamma compositum in patients with APN and DPN has the experimental rationale of its effects on pathogenic mechanisms of polyneuropathies. Results of many placebo controlled studies demonstrated clinical efficiency of Milgamma and Milgamma compositum in the treatment of APN and DPN.

References

  1. Анисимова Е.И., Данилов А.Б. Эффективность бенфотиамина в лечении алкогольной полиневропатии // Журнал неврологии и психиатрии им. С.С. Корсакова. 2001. № 4. С. 216-221.
  2. Анисимова Е.И., Данилов А.Б. Невропатический болевой синдром: клинико-нейрофизиологический анализ // Неврологический журнал. 2003. № 10 С. 15-22.
  3. Верткин А.Л., Городецкий В.В. Преимущества бенфотиаминсодержащих препаратов в лечении диабетической полинейропатии // Фарматека. 2005. № 10. С. 1-6.
  4. Данилов А.Б. Витамины группы В в лечении острых болей в спине: миф или реальность? // Лечащий врач. 2007. № 4. С. 1-8.
  5. Данилов А.Б., Давыдов О.С. Невропатическая боль // Боргес. 2007 С. 191.
  6. Садеков Р.А., Данилов А.Б., Вейн А.М. Лечение диабетической полиневропатии препаратом Мильгамма 100 // Журнал неврологии и психиатрии. 1998. № 9. С. 30-32.
  7. Строков И.А., Строков К.И., Солуянова Т.В. От тиамина к бенфотиамину: современные подходы в лечении диабетической полиневропатии // Фарматека. 2006. № 7. С.57-61.
  8. Строков И.А., Баринов А.Н., Новосадова М.В. и др. Клинические методы оценки тяжести диабетической полиневропатии // Неврологический журнал. 2000. № 5. С.14-19.
  9. Строков И.А., Алексеев В.В., Айзенберг И.В., Володина А.В. Острая алкогольная полиневропатия // Неврологический журнал. 2004. Т. 9. № 1. С. 45-50.
  10. Левин О.С. Полиневропатии // МИА. 2005. С. 491
  11. Маркина О.А. Значение лекарственной формы и пути введения витаминов группы В для обеспечения эффективного лечения диабетической полиневропатии // Клиническая фармакология и терапия. 2003. № 2. С. 6-9.
  12. Ammendola A, Tata MR, Aurilio C, et al. Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subject. Alcohol and Alcoholism 2001; 36:271-75.
  13. Ang CD, Alviar MJ, Dans AL, et al. Vitamin B for treating peripheral neuropathy. Cochrane Database Syst Rev 2008;16(3):CD004573.
  14. Babaei-Jadid R, Karachalias N, Ahmedm N, et al. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003;52:2110-20.
  15. Bitsch R. Biovailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative. Ann Nutr Metab 1991;35:292-96.
  16. Dyck PJ, Dyck PJ. Diabetic polyneuropathy. In Diabetic Neuropathy еds by Dyck PJ, Thomas PK. 2nd ed. Philadelphia WB Saunders 1999:255-78.
  17. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA 2002;287:3116-26.
  18. Fujiwara M. Allithiamine and its properties. J Nutr Sci Vitaminol (Tokyo) 1967;22:57-62.
  19. Greb A, Bitsch R. Comporative bioavailability of various thiamine derivatives after oral administration. Int J Clin Pharmacol Ther 1998;36:216-21.
  20. Haupt E, Doppelblinde, placecokontrollierte untersuchung zur klinischen wirksamkeit und vertuglichkeit von benfotiamin ankermann dragees bei diabetischen polyneuropathien. Kongreubericht 1995;32:2.
  21. Haupt E, Ledermann H, Köpcke W. Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 2005;43:71-7.
  22. Koike H, Mori K, Misu K, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001;56:1727-32.
  23. Koike H, Iijima M, Suqiura M, et al. Alcoholic neuropathy in clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003;55:19-29.
  24. Ledermann H, Widey K.D. Behandlung der manifesten diabetichen polyneuropathie. Therapiewoche 1989;39:1445-49.
  25. Pomero F, Molinar MA, La Selva M, et al. Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose. Acta Diabetol 2001;38:135-38.
  26. Ryle PR, Thompson AD. Nutrition and vitamins in alcoholism. Contemp Issues Clinic Biochem 1984:188-224.
  27. Schmidt J. Wirksamkeit von benfotiamin bei diabetischer neuropathie - breite anwendungsbeobachtung unterstreicht praxisbenefit. Der KaSSENARZT, Helt 2002; 14/15:40-43.
  28. Schreeb KH, Freudenthaler S, Vormfelde SV, et al. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 1997;52:773-88.
  29. Stirban A, Negrean M, Statmann B, et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006;29:2064-71.
  30. Stracke H, Lindermann A, Federlin K. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 1996;104:311-16.
  31. Stracke H, Gaus W, Achenbach U, et al. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical trial. Exp Clin Endocrinil Diabetes 2008;16:1-6.
  32. Windebank AJ. Polyneuropathy due to nutritional deficiency and alcoholism. Peripheral neuropathy eds. by Dyck PJ, Thomas PK, 3th ed. W.B.Saunders 1993:1310-21.
  33. Winkler G, Pal B, Nagyberanyi E, et al. Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. Arzneimittelforschung 1999;49:220-24.
  34. Woelk H, Lehrl S, Bitsch R, et al. Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I STUDY). Alcohol&Alcoholism 1998;33:631-38.
  35. Victor M, Adams RD. On the etiology of the alcoholic neurologic diseases. With special references to the role of nutrition. Am J Clin Nutr 1961;9:379-83.
  36. Volvert ML, Seven S, Piette M, et al. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechamisms of action and a different ppharmacological profile then lipid-soluble thiamine disulfide derivatives. BMC Parmacol 2008;8:10.
  37. Zambelis T, Karandreas N, Tzavellas E, et al. Large and small fiber neuropathy in chronic alcohol-dependent subject. J Periph Nerv Sys 2005;10:375-38.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies